Treatment and clinical outcome of young (age 40 and younger) patients with advanced non-small cell lung (NSCLC).

e18117 Background: NSCLC is a very uncommon in pts ≤ 40 years and is usually considered as a distinct disease, with a better prognosis compared to older pts. In recent years, third generation drugs...